Diomune participates in 3 projects funded by the European Commission:
The ASFORCE project aims to identify and solve major problems in relation to the prevention of the entry of African Swine Fever (ASF) in the European Union, focusing primarily on the threat posed by the emergence and spread of the disease in Eastern Europe. The ASFORCE project has been funded by the Framework Programme 7 of the European Union.
“Host Microbe Interactions in Health and Disease” is a network training program funded by the actions of the European Union Marie Curie. The project focuses on the study of the interaction of microorganisms with the host in health and disease conditions. The participants are five academic institutions from three European countries, among which is Diomune SL.
The project aims to study the molecular aspects of TLR4 activation and signaling, using compounds and nanoparticles that selectively interact with some components (mainly MD-2 and CD14) of the TLR4 recognition system. Diomune S.L. is part of TOLLerant project consortium together with other European groups with extensive experience in chemistry, biology, biophysics, biochemistry and pharmacology. This project has received funding from the Research and Innovation Programme of the European Union Horizon 2020 under the grant agreement Marie Sklodowska-Curie.